Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cell & Bioscience|July 27, 2023
Cutting-edge advances in modeling the blood-brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brainAmit Sharma, Diogo C Fernandes, Rui L Reis, et al.
International Journal of Molecular Sciences|May 14, 2022
Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma CellsPhilippe Aretz, Donata Maciaczyk, Suad Yusuf, et al.
BMJ Open|November 30, 2023
Healthy grocery delivery in the usual care for adults recovering from an acute coronary event: protocol for a three-arm randomised controlled trialAndrew N Reynolds, Fiona Hood, Ross Wilson, et al.
The Journal of Clinical Investigation|May 24, 2016
Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activationAnna Waldhuber, Manoj Puthia, Andreas Wieser, et al.
Cancers|July 9, 2022
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like CellsSuad Yusuf, Philippe Aretz, Ann-Christin Nickel, et al.
Annals of Hematology|June 25, 2016
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016Andrew J Ullmann, Martin Schmidt-Hieber, Hartmut Bertz, et al.
Annals of Hematology|June 22, 2014
Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and OncologyDaniela Tacke, Dieter Buchheidt, Meinolf Karthaus, et al.
Haematologica|August 24, 2011
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patientsMaria J G T Vehreschild, Arne M K Meissner, Oliver Andreas Cornely, et al.
Cell Reports. Medicine|May 9, 2026
Dual-system engineered bacteria and dendritic cells enable precise intratumoral IL-12 delivery and potent antitumor immunityYuan Deng, Heng Liang, Arabella H Wan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2016
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)Michael Kreuter, Johan Vansteenkiste, Jürgen R Fischer, et al.
Pageof 5